The Role of the CopA Copper Efflux System in Acinetobacter baumannii Virulence.
Saleh F AlquethamyMarjan KhorvashVictoria G PederickJonathan J WhittallJames C PatonIan T PaulsenKarl A HassanChristopher A McDevittBart A EijkelkampPublished in: International journal of molecular sciences (2019)
Acinetobacter baumannii has emerged as one of the leading causative agents of nosocomial infections. Due to its high level of intrinsic and adapted antibiotic resistance, treatment failure rates are high, which allows this opportunistic pathogen to thrive during infection in immune-compromised patients. A. baumannii can cause infections within a broad range of host niches, with pneumonia and bacteraemia being associated with the greatest levels of morbidity and mortality. Although its resistance to antibiotics is widely studied, our understanding of the mechanisms required for dealing with environmental stresses related to virulence and hospital persistence, such as copper toxicity, is limited. Here, we performed an in silico analysis of the A. baumannii copper resistome, examining its regulation under copper stress. Using comparative analyses of bacterial P-type ATPases, we propose that A. baumannii encodes a member of a novel subgroup of P1B-1 ATPases. Analyses of three putative inner membrane copper efflux systems identified the P1B-1 ATPase CopA as the primary mediator of cytoplasmic copper resistance in A. baumannii. Using a murine model of A. baumannii pneumonia, we reveal that CopA contributes to the virulence of A. baumannii. Collectively, this study advances our understanding of how A. baumannii deals with environmental copper toxicity, and it provides novel insights into how A. baumannii combats adversities encountered as part of the host immune defence.
Keyphrases
- acinetobacter baumannii
- pseudomonas aeruginosa
- oxide nanoparticles
- multidrug resistant
- drug resistant
- escherichia coli
- biofilm formation
- end stage renal disease
- cystic fibrosis
- newly diagnosed
- oxidative stress
- chronic kidney disease
- ejection fraction
- molecular docking
- healthcare
- clinical trial
- human health
- gene expression
- climate change
- single cell
- dna methylation
- genome wide
- intensive care unit
- risk assessment
- smoking cessation
- drug induced
- community acquired pneumonia
- molecular dynamics simulations
- stress induced
- placebo controlled